Business · 07/04/2026Updated: 10/16/2026 · 1 min read
FDA Awards Priority Review Voucher to LOARGYS (pegzilarginase-nbln) Sponsor
Summary
The FDA has issued a priority review voucher to Immedica Pharma AB, the manufacturer of LOARGYS (pegzilarginase-nbln), a rare pediatric disease product approved on February 23, 2026.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →